A federal court has banned the sale of new Apple Watches in the United States on the grounds the blood oxygen trackers of the watches violate the intellectual property rights of the medical technology company Masimo.
The U.S. Court of Appeals for the Federal Circuit ruled on Wednesday that it would reinstate its ban on selling the Apple Watch Series 9 and the Apple Watch Ultra 2. This will stop the company from selling any new models of the Series 9 and Ultra 2 in the U.S. because of the blood oxygen trackers.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.